Sarepta Therapeutics reported $165.96M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 124.93M 14.92M
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
Alnylam Pharmaceuticals ALNY:US $ 154.97M 35.33M
Amgen AMGN:US $ 5097M 208M
Biocryst Pharmaceuticals BCRX:US $ 40.38M 9.24M
Biogen BIIB:US $ 2267.1M 48.2M
Biomarin Pharmaceutical BMRN:US $ 305.2M 69.43M
Bluebird Bio BLUE:US $ 2.97M 10.8M
Daiichi Sankyo 4568:JP Y 178489M 428M
Eli Lilly And LLY:US $ 5342M 555.1M
Esperion Therapeutics ESPR:US $ 8.85M 30.01M
Gilead Sciences GILD:US $ 6198M 1371M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Insmed INSM:US $ 36.57M 2.04M
Intercept Pharmaceuticals ICPT:US $ 92.17M 3.79M
IONIS PHARMACEUT IONS:US $ 130M 7.21M
Moderna Inc MRNA:US 4.25B 643M
Nektar Therapeutics NKTR:US $ 19.61M 1.05M
Neurocrine Biosciences NBIX:US $ 291.8M 6M
Pfizer PFE:US $ 14163M 2178M
Ptc Therapeutics PTCT:US $ 132.2M 22.89M
Regeneron Pharmaceuticals REGN:US $ 2999.6M 1445.2M
Sarepta Therapeutics SRPT:US $ 165.96M 21.39M
Ultragenyx Pharmaceutical RARE:US $ 77.47M 6.37M
Vertex Pharmaceuticals VRTX:US $ 1747.65M 182.25M
YTE INCY:US $ 778.52M 105.44M
Zogenix ZGNX:US $ 21.32M 3.75M